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 Introduction: As obesity continues to be a major public health concern, 
exercise is continually at the forefront of combating this epidemic.  This thesis 
aims to examine how two different doses of exercise may affect the “hunger 
hormone”, ghrelin; in postmenopausal, non-obese women.  Methods: 54 non-
obese postmenopausal women were randomly assigned to either a higher dose 
(energy expenditure = 14 kilocalories/per kilogram of body weight/per week) or 
lower dose (energy expenditure = 8 kcal/kg/week) aerobic exercise training group 
for 16 weeks. Fasting blood samples were taken at baseline and at post 
intervention for analysis of ghrelin via multiplex immunoassay.  Results: Only the 
higher dose exercise group had a decrease in ghrelin concentration following 16 
weeks of moderate intensity aerobic exercise. Conclusion: Higher dose aerobic 
exercise training significantly decreased fasting ghrelin concentration and 
increased VO2 in non-obese postmenopausal women while the lower-dose 
chronic exercise training did not. 
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CHAPTER 1 
MANUSCRIPT 
Obesity is a global health problem that is associated with increased risks 
for several diseases such as type 2 diabetes and cardiovascular disease (1).  In 
recent years, the prevalence of overweight and obesity in middle aged and older 
women has continued to increase (1).  By 2025, the North American Menopause 
Society has determined that the population of older adults is estimated to 
increase considerably, and those that are overweight or obese will most likely 
require additional clinical care; further extending the cost of healthcare related to 
obesity.  With this in mind, it is evident that this population requires additional 
attention in regards to understanding and controlling this trend (1). 
 Overweight and obesity most likely results from a chronic imbalance of 
energy intake and energy expenditure.  Energy balance and body weight and 
composition are regulated by many factors including a complex network of 
hormones with energy regulating properties, such as detecting changes in the 
body’s energy balance, relaying that information to the central processing centers 
in the brain, and inducing changes in energy intake/expenditure.  These 
hormones are commonly grouped into two categories, either episodic/short term, 
or tonic/long term.  Ghrelin is widely recognized as the main episodic regulator of 
energy intake (2).  It plays a role in the regulation of energy balance by 
increasing appetite and initiating food intake, as well as reducing fat utilization 
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(3).  Total plasma ghrelin concentrations increase pre-prandially and fall post-
prandially (4); however the post-prandial decrease in ghrelin concentration is not 
seen in obese population (5).  Ghrelin infusion studies have found a continuous 
infusion of exogenous ghrelin can increase appetite sensations inboth obese and 
lean participants (6). Ghrelin concentrations are found in circulation to be 
inversely proportional to body weight – higher circulating ghrelin concentrations 
are found in lower body weights, and lower circulating levels are found in high 
body weights (5, 7, 8).  Following weight change, ghrelin typically responds in a 
compensatory fashion, with concentrations increasing with weight loss, and 
decreasing with weight gain (7).  Studies of long term caloric restriction ranging 
from three to six months resulting in significant weight loss have resulted in 
increased ghrelin concentrations (5, 9).   
 Exercise as a means to induce negative energy balance and potentially 
weight loss has been suggested to increase fasting ghrelin concentrations and 
therefore, appetite sensations.  However, there is evidence suggesting that the 
effect of exercise on ghrelin may be different from weight loss resulting from 
caloric restriction (4).  Several previous studies have investigated the response of 
ghrelin concentrations to chronic exercise training; however the results of these 
studies are inconclusive (4, 7, 10-12). The different doses of exercise used in the 
studies may be a factor contributing to the inconsistent findings, but this has not 
been investigated in the same study.  Additionally, obese individuals may have a 
different response to an exercise intervention from normal weight individuals 
(11).  Research by Heden et al found normal weight individuals had a decrease 
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in fasting ghrelin concentration 12 hours after a one-hour moderate intensity 
exercise bout, but this decrease was absent in obese individuals (11).  Most 
previous exercise training studies, however, have examined ghrelin response in 
obese individuals.  To our knowledge, normal weight older women are a segment 
of the population that have yet to be studied in this capacity.   
 The purpose of this study was to investigate the ghrelin response to two 
different doses of chronic aerobic exercise training in non-obese older women 
without a dietary intervention.  We hypothesized that in women performing the 
higher exercise dose would have a decrease in fasting circulating ghrelin 
concentration, while women performing a lower dose of exercise would not 
experience the decrease in fasting ghrelin concentration. 
Methods 
 This study used data collected in the Women’s Energy Expenditure in 
Walking Programs Study (Clinicaltrials.gov identifier: NCT01722136).  The 
WeWalk Study was a 4-month randomized control trial to investigate the effects 
of moderate intensity aerobic exercise of two different doses on energy 
expenditure in inactive older women, with the higher-dose group meeting the 
current public health guidelines for the recommended amount of moderate 
intensity aerobic exercise per week, while the lower-dose group will fall below the 
recommended amount.  Study procedures were reviewed and approved by the 
University of South Carolina institutional Review Board in Columbia, South 
Carolina.  All participants signed a written informed consent. 
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Participants 
 The participants of the WeWalk Study were non-obese (body mass 
index, BMI, 18 – 30 kg/m2) older women (60-75 years) from the Columbia 
metropolitan area.  They were recruited through advertisements in the local 
newspapers, emails lists, and lunch n’ learn programs.  Briefly, exclusionary 
criteria included: medications known to affect exercise performance or 
metabolism, self-reported or upon medical examination, signs of metabolic 
disorders such as diabetes or thyroid disorders, heart disease, kidney disease, 
lung disease, cancer diagnoses within the last 5 years (except skin cancer), large 
weight fluctuations in the last 3 months ( >3%), currently smoking, current 
participation in another intervention, physically active (greater than 20 minutes x  
3 times per week of structured exercise) during the past 3 months, any 
contraindications to exercise, or abnormal responses during the graded exercise 
test (see below). 
Graded exercise test 
 Participants completed a maximal graded treadmill test at baseline and 
post-intervention.  The test was an incremental protocol, participants walked at a 
self-selected pace which remained constant throughout the duration of the test.  
Every 2 minutes, the incline of the treadmill was increased by 2%.  Volume of O2 
(VO2) and CO2 (VCO2) was measured via a metabolic cart (TrueOne 2400, 
ParvoMedics, Sandy, UT, USA).  Heart rate via a standard 12-lead ECG (Q-
Stress; Cardiac Science, Bothell, WA, USA) was monitored by a trained medical 
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personnel. Blood pressure readings were taken approximately 30 seconds into 
each stage of the test.  For the test to be considered satisfactory, two of four 
criteria had to be met: a plateau in heart rate or VO2; respiratory exchange ratio 
greater than or equal to 1.10; a maximum heart rate greater than 90% of age-
predicted maximal heart rate (= 220-age); or a rating of perceived exertion 
greater than or equal to 17 on the Borg scale.  VO2peak was determined by the 
maximal 30-second averaged VO2 value during the test. 
Exercise Intervention 
 Participants were randomized into one of two moderate-intensity 
exercise groups.  The lower-dose group had an energy expenditure goal of 8 
kilocalories (kcal) per kilogram (kg) of body weight per week, and the higher-dose 
group had an energy expenditure goal of 14 kcal/kg of body weight per week.  All 
training sessions were supervised and occurred at the Clinical Exercise 
Research Center at the University of South Carolina.  Both groups exercised for 
16 weeks at an intensity of 50-55% of the participant’s heart rate reserve (HRR), 
which was calculated using information obtained from each woman’s graded 
exercise test.  Due to the participants being inactive prior to their participation in 
the study, training intensity started at 40% of HRR and was increased by 5% 
every two weeks until the target level of 50-55% was achieved.  The exercise 
target was reached within 5 weeks for women in the lower dose group and 8 
weeks for those in the higher dose group. Heart rate monitors (FT1; Polar; Lake 
Success, NY, USA) were worn during training sessions to ensure participants 
were exercising at the desired intensity throughout each exercise session.  Heart 
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rate was monitored and recorded every 5 minutes throughout each training 
session, and blood pressure was measured before, at the midpoint of the 
exercise session, and after the exercise sessions.  Women in the lower and 
higher-dose groups walked an average of 105 minutes and 160 minutes per 
week, respectively. Most women walked 3 times a week, although a few women 
in the higher-dose group walked 4 times a week.   
Body Composition 
 The dual-energy absorptiometry (enCORE, GE Healthcare model 8743, 
Waukesha, WI) full body scan was utilized to measure body fat percentage, lean 
mass (kg), fat mass (kg) and fat free mass (kg) at baseline and post-intervention.  
Height was measured to the nearest 0.1cm without shoes, and weight was 
measured to the nearest 0.1kg while the participant was wearing lightweight 
scrubs.  Two measurements for both height and weight were taken, and 
averages were used to calculate BMI (kg/m2).   
Blood Sample Collection and Analysis 
Venous blood samples were collected at baseline and following the 
exercise intervention. Participants were instructed to fast (not including water) for 
at least 12 hours prior to blood draw visits.  Blood samples were drawn into 
EDTA tubes, centrifuged at 3,000 rpm for 20 minutes at 4 degrees Celsius.  
Plasma was then aliquoted into Eppendorf tubes and stored at -80 degrees 
Celsius until analysis.   
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Plasma samples were thawed and re-centrifuged at 3,000 rpm at 4C° for 
20 minutes to remove any potential particulates before analysis of ghrelin 
concentration.  Plasma ghrelin was quantified by a multiplex immunoassay 
(Human Metabolic Hormone Magnetic Bead Panel, Millipore, Billerica, MA) per 
manufacturer instructions on a Magpix multiplexing system (Luminex, Austin, 
Texas, USA). The assay has a minimum detectable concentration of 13 pg/ml. 
The intra-assay coefficient of variance (CV) in our laboratory was < 10% and 
inter-assay CV was < 7%. All samples were run in duplicates. 
Statistical Analysis 
Descriptive statistics were first examined and are reported as mean ± SD.  
Change values in body weight, fat mass, fat-free mass, and ghrelin concentration 
were calculated using post intervention values subtracted from baseline values. 
Baseline and change values were compared between the exercise groups using 
one-way analysis of variance (ANOVA). Within each group, paired t-test was 
used to determine if values at post-intervention were different from baseline. 
ANOVA with repeated measures were used to determine the changes following 
exercise training were different between the two exercise groups.  A p value of < 
0.05 was used to denote statistical significance.  Because of the reported 
association between body weight and body composition with ghrelin 
concentration in the literature, regression analyses were used to determine 
corrections between baseline and changes in body weight, fat mass, fat-free 
mass, and VO2peakwith ghrelin concentration.  The SAS software (version 9.4, 
SAS Institute, Cary, NC) were used to perform analyses.   
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Results 
 Of the 54 participants, the majority were Caucasian (89%) and 87% of 
the participants had at least some college education.  As shown in Table 1.1, at 
baseline there were no significant differences between groups for age (years), 
height (cm), weight (kg), BMI (kg/m2), VO2 (ml/kg/min), fat mass (kg), fat free 
mass (kg), percent body fat, systolic & diastolic blood pressure(mmHg), or fasting 
ghrelin concentration(pg/ml) between groups. In the entire sample, body weight, 
body composition or VO2 peak were not correlated with ghrelin concentration (p > 
0.05 for all). 
 Following the exercise training, repeated measures ANOVA revealed a 
significant group by time interaction for VO2 peak [F(1,52) = 7.09, p = 0.0103] 
only.  Table 1.2 shows change values for body weight, fat mass, lean mass, 
percent fat, and VO2 by group.  Within the lower dose group, there was no 
change in weight, fat mass, lean mass, percent body fat, or VO2 peak from 
baseline to post-intervention measurements. Within the higher-dose group, 
following the exercise intervention, there was no change in weight, fat mass, lean 
mass, or percent body fat; but VO2 peak significantly increased. 
As shown in table 1.3, there was no change in fasting ghrelin 
concentration in the lower-dose exercise group from baseline to post-
intervention.  However, in the higher-dose exercise group, there was a significant 
decrease by 27.43 ± 54.78 pg/ml in fasting ghrelin concentration from baseline to 
post-intervention.  Figure 1.1 provides a graphical representation of the changes 
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in fasting ghrelin concentration from baseline to post-intervention for the higher-
dose exercise group, and figure 1.2 addresses the lower-dose exercise group 
fasting ghrelin concentrations from baseline to post-intervention.  Additionally, 
regression analysis revealed no baseline body weight, body composition, and 
VO2 peak were predictors of post-intervention fasting ghrelin concentration; nor 
were any change values in these variables correlated with post-intervention 
fasting ghrelin. 
Discussion 
 To our knowledge this is the first study to determine the effect of exercise 
dose on changes in ghrelin concentration in normal weight older women. We 
found that fasting ghrelin significantly decreased in the higher-dose exercise 
group but not in the lower-dose group.   
 These results are in line with our hypothesis, which was there will be 
different changes in ghrelin concentration in women participating in exercise of 
two different doses. The participants in the higher-dose group exercised at 
moderate-intensity for an average of 160 minutes per week and the lower-dose 
group exercise for 105 minutes per week. Our results therefore indicate non-
obese postmenopausal women who meet the public health recommendations for 
150 minutes or more of moderate intensity aerobic exercise per week may 
experience a significant decrease in fasting ghrelin concentrations; while women 
who are participating in moderate intensity aerobic exercise but are not meeting 
the recommendation of 150 minutes per week may not experience the changes.    
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Decreased fasting ghrelin after exercise training has been reported in 
previous studies in adolescents and mice (13, 14).  Prado et al examined the 
effect of low and high intensity aerobic exercise training on appetite regulating 
hormones.  The participants were obese adolescents, randomized into high or 
low intensity training groups for 12 weeks.  The high intensity group exercised at 
an intensity that corresponded with their respective ventilator threshold, and the 
low intensity group exercised at an intensity approximately 20% below their 
respective ventilator thresholds.  Exercise sessions were isoenergetic, with 
energy expenditure set at 350 kcal per session.  The results of this study were 
intriguing, as there was a decrease in ghrelin concentration in both exercise 
groups compared to baseline levels, as well as a decrease in body mass in both 
groups (13).  Research by Wang et al in Sprague-Dawly rats found decreased 
hypothalamic ghrelin concentrations in obese rats subjected to long-term 
exercise which included 40 minutes of running, 5 days per week, for 8 weeks. 
Results were compared to long-term controls.  Following 8 weeks of exercise, the 
long-term exercise rats had a decrease in body weight when compared to the 
long-term controls.  In this study, the researchers concluded it was the decrease 
in hypothalamic ghrelin concentration that ultimately led to the decrease in body 
weight (14).  There are a multitude of potential theories as to why despite weight 
loss, fasting ghrelin concentrations decreased. These theories are discussed 
below.  
 Redistribution of blood flow is a commonly proposed mechanism of 
action.  During exercise, blood is redirected away from the splanchnic area to 
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keep up with the increased need of working skeletal muscle; being reduced up to 
80% during high intensity exercise (15).  Because ghrelin is secreted from the 
stomach, the reduced blood flow to this area may offer an explanation as to why 
reduced ghrelin levels are seen post-exercise; however this is likely an acute 
effect. Adiposity signals such as leptin and insulin also appear to play a role.  
There is an inverse reciprocal relationship between leptin and ghrelin; with 
research revealing a direct inhibitory effect of leptin on the production of ghrelin 
(16).  Therefore it is possible that alterations in circulating ghrelin concentration 
may be a secondary change due to changes in body weight.   
Lending interest to the theory of a threshold existing, where an individual 
would have to lose a certain amount of weight before physiological changes such 
as changes in ghrelin concentration would occur, is a study done by Mason et al, 
in overweight and obese postmenopausal women.  The study was 12 months in 
duration, and one intervention group was assigned to a diet only intervention.  At 
the conclusion of the 12 months, the diet only group had a non-significant 
increase in ghrelin of +87 pg/ml compared to baseline levels, or an increase of 
6.5%.  Upon further examination, the researchers found increases in ghrelin 
concentration were significantly associated with larger amounts of weight loss.  
Among women who lost 5-10% of their baseline body weight, ghrelin increased 
by an average of 60pg/ml compared to baseline levels; and in women who lost 
10% or more of their baseline body weight, there was an average increase 148 
pg/ml, or a 10.7% increase (7).   
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Ravussin et al were the first to report the impact of exercise training on 
circulating ghrelin in a cohort of healthy, young men (12). Following 93 days of a 
cycling intervention, where the participants performed two bouts of cycling 
exercise per day to expend 1000 kcal per day, resulting in a 6% body weight 
loss, there was a 26% increase in fasting ghrelin concentration (12).   Another 
study by Leidy et al furthers this theory.  In this study, the participants in this 
study performed moderate intensity aerobic exercise 5 times per week for a 
duration that expended 2092 kJ per session (500 kcal).  In this particular study, 
the diet of the participants was tightly controlled, with all participant meals being 
provided by the research study team.  The results found exercise without 
significant weight loss (<1.5kg) resulted in no changes in fasting plasma ghrelin 
concentration.  However, in participants who experienced a significant amount of 
weight loss (>1.5kg) fasting ghrelin concentration increased twofold (17). The 
findings of Leidy et al have been extended to postmenopausal overweight and 
obese women by Foster-Schubert et al, who found increased concentrations of 
fasting plasma ghrelin only in the participants who lost weight following a 12 
month aerobic exercise intervention of moderate intensity.  Their results indicate 
ghrelin concentrations increased in a “step-wise” fashion, with larger changes 
occurring in the participants who lost larger amounts of weight (18).  These 
results have been further supported by others who have reported changes in 
ghrelin levels positively correlated with the extent of weight loss experienced by 
the participants (8) and another study reporting unchanged fasting plasma 
ghrelin concentrations following 12 weeks of moderate intensity aerobic exercise 
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training 5 times per week, in healthy normal weight women who did not lose 
weight (19).  All of the aforementioned studies were done in either males (12), 
healthy, normal weight young women (17), overweight and obese middle-aged 
women (8), or postmenopausal overweight and obese women (18).  Our study 
was conducted in non-obese (BMI 18-30 kg/m2) postmenopausal women, which 
appear to be a specific segment of the population which had yet to be 
investigated in this capacity.  Previous studies have also focused on an “exercise 
vs. control” approach, whereas this study sought to compare two different doses 
of exercise, as it may not be the exercise itself, but the resulting weight loss 
which then stimulates the change in ghrelin concentration.  
 When measuring a hormone that is known to fluctuate over the course of 
the day such as ghrelin, one should take into consideration not only the possible 
effects of the time of day, but also the potential cumulative effects of energy 
intake.  To have a clear picture of intervention effects on ghrelin, it would be ideal 
to measure both fasting and postprandial concentrations.  Ghrelin concentration 
is at its lowest levels around approximately 6:00am, and displays meal related 
increases and decreases throughout the day; with nocturnal peak levels 
occurring between 1:00am and 2:00am.  It has also been shown that acute 
changes in ghrelin concentration over a normal day of eating behavior in normal 
weight sedentary women is significantly correlated with calorie intake (17).  For 
this study only collected fasting blood samples were collected, and therefore we 
are not able to examine if there is any change in postprandial concentrations or 
the difference between high and low concentrations within a day.  The 
 14   
participants were also free living, so the researchers had no control over the diet 
being consumed by the participants in terms of macronutrient breakdown or total 
calorie intake.  Also, the duration between blood draw and the last exercise 
session varies from one to several days, and it is unknown how long any effects 
of acute or chronic exercise lasts. Therefore, we cannot differentiate whether any 
effect is due to the last exercise session or exercise training. Additionally, 
participants were not assessed for feelings of hunger or appetite at any point 
during the study; therefore, we cannot determine whether the ghrelin response to 
exercise training is associated with appetite change.  Lastly, these results only 
apply to older non-obese healthy women since ghrelin response to exercise 
training may be influenced by age, sex, and body weight status.  The change in 
ghrelin concentration in the high dose group corresponded to a medium effect 
size of 0.56 (Cohen’s d); we had 75% power to detect such a change with n=24. 
The change in ghrelin in the low dose group corresponded to a less than small 
effect size of 0.16.  
All exercise sessions being monitored by trained study staff was a major 
strength of the study, ensuring all of the exercise sessions were indeed occurring 
at the correct intensity and meeting calorie expenditure goals. The inclusion of 
two different doses of exercise allowed us to examine the effect of exercise dose, 
and if there may be a certain energy expenditure threshold that has to be met in 
order to illicit changes in ghrelin concentration.  Finally, the inclusion of non-
obese women allowed us to examine the ghrelin response in individuals with 
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relatively normal metabolism rather than obese individuals who may already 
present abnormal metabolic responses.  
In conclusion, this study found that fasting ghrelin decreased in older 
women who participated moderate-intensity exercise of an average of 160 
minutes but not in those who exercised at a lower-dose. These results suggest 
that meeting the public health physical activity guideline may induce decreases in 
ghrelin responses.  However, whether this change is linked to decreased appetite 
and subsequent weight maintenance worth further investigation.   
Future Directions 
Future research examining the ghrelin response to long term aerobic 
exercise should explore the role that the ghrelin receptors play regarding the 
physiological ghrelin response to exercise; as not only the circulating 
concentration of the hormone of interest is important, but also the sensitivity, 
number, and affinity of the respective receptors. Recent research has also 
indicated an anabolic effect of ghrelin (20) which should also be further examined 
in respect to chronic aerobic exercise training.  This research would also be more 
suitable for detecting changes in ghrelin receptors in skeletal muscle or body fat, 
by way of muscle biopsies. Additional research is also needed to further define 
the physiological mechanisms in regards to changes in circulating ghrelin 
concentration in response to different exercise interventions.  
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Table 1.1: Baseline characteristics of participants by exercise groups 
 Lower Dose Higher Dose p value 
Age (years) 65.5 ± 4.6 64.9 ± 4.2 0.61 
Height (cm) 161.9 ± 6.7 163.6 ± 6.2 0.35 
Weight (kg) 67.3 ± 10.8 68 ± 9.4 0.81 
BMI kg/m2 25.8 ± 4.2 25.5 ± 4.2 0.79 
FM (kg) 26.8 ± 7.9 26.8 ± 7.9 0.966 
FFM (kg) 41.5 ± 4.2 42.3 ± 5.3 0.54 
% Body Fat 38.3 ± 6.8% 38.3 ± 6.6% 0.99 
SBP (mmHg) 127.2 ±  13.1 126.8 ± 9.45 0.99 
DBP (mmHg) 74.6 ± 8.7 75.7 ± 6.3 0.54 
Ghrelin (pg/ml) 76.2 ± 77.3 56.3 ± 54.4 0.28 
VO2 (ml/kg/min) 20.2 ± 3.5 20.2 ± 3.5 0.85 
 
Data are presented as mean ± SD.  P values are for between group 
comparisons. 
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Table 1.2: Anthropometric and aerobic fitness change values within group 
 
Variables Lower Dose Higher Dose 
 Change P value Change P value 
Wt (kg) 2.0 ± 8.1 0.79 1.2 ± 2.3 0.65 
FM (kg) 0.6 ± 1.7 0.77 1.3 ± 2.2 0.18 
LM (kg) 0.1 ± 0.8 0.91 0.2 ± 1.2 0.84 
% Body 
Fat 0.5 ± 1.4 0.79 1.1 ± 1.9 0.57 
VO2 
(ml/kg/min) -0.8 ± 2.8 0.38 -3.0 ± 3.1* 0.02 
 
Data are presented as mean ± SD.  P values are paired t-tests within each 
exercise group.  Change values were calculated by subtracting post-intervention 
values from baseline values. * signifies statistical significance p < 0.05 
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Table 1.3: Ghrelin change values within group 
 
Ghrelin Lower-Dose Higher-Dose 
Baseline pg/ml 77.2 ± 77.3 63.5 ± 70.7 
Post-Intervention pg/ml 56.2 ± 54.4 28.8 ± 14.8 
∆ pg/ml 12.7 ± 93.3 27.4 ± 54.8 
P value 0.51 0.02 *  
 
Data are presented as mean ± SD. P values are for paired t-tests within each 
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Figure 1.1 shows baseline and post-intervention fasting ghrelin concentration for 
each participant in the higher-dose exercise group (n=24). Data are presented as 
mean ± standard error. * signifies statistical significance p < 0.05 
  
* 
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Figure 1.2 shows baseline and post-intervention fasting ghrelin concentration for 
each participant in the higher-dose exercise group (n=30). Data are presented as 
mean ± standard error. 
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CHAPTER 2 
THESIS PROPOSAL
Obesity is a global health problem that is associated with increased risks 
for several diseases such as type 2 diabetes and cardiovascular diseases. In 
recent years, the prevalence of overweight and obesity in middle aged and older 
women has continued to increase (1). By 2025, the North American Menopause 
Society has determined the population of older adults is estimated to increase 
considerably, and those that are overweight or obese will more than likely need 
additional clinical care; further extending the cost of healthcare related to obesity.  
With this in mind, it is evident that this population requires additional attention in 
regards to understanding and controlling this trend (1). 
Overweight and obesity most likely results from a chronic imbalance of 
energy intake and energy expenditure.  Energy balance and body weight and 
composition are regulated by many factors including a complex network of 
hormones with energy regulating properties, such as detecting changes in the 
body’s energy balance, relaying that information to the central processing centers 
in the brain, and inducing changes in energy intake/energy expenditure.  These 
hormones are commonly grouped into two categories, either episodic/short term, 
or tonic/long term.  Ghrelin is widely recognized as the main episodic regulator of 
energy intake (2).  It plays a role in the regulation of energy balance by 
increasing appetite and initiating food intake, as well as reducing fat utilization 
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(3).  Total plasma ghrelin concentrations increase pre-prandially and fall post-
prandially (4); however, the post-prandial decrease in ghrelin concentration is 
absent in obese populations (5). Ghrelin concentrations are found in circulation to 
be inversely proportional to body weight – higher circulating ghrelin 
concentrations are found in lower body weights, and lower circulating levels 
found in higher body weights (5, 7, 8). Following weight change, ghrelin typically 
responds in a compensatory fashion, with concentrations increasing with weight 
loss, and decreasing with weight gain (7).  Studies of long term caloric restriction 
ranging from three to six months resulting in significant weight loss have resulted 
in increased ghrelin concentrations (5, 9).  
Exercise as a means to induce negative energy balance and potentially 
weight loss has been suggested to increase fasting ghrelin concentrations and 
therefore appetite sensations.  There is evidence suggesting that the effect of 
exercise on ghrelin may be different from caloric restriction induced weight loss 
(4).  Several previous studies have investigated the response of ghrelin 
concentrations to acute exercise bout and chronic exercise training; however, 
results of the studies are inconclusive (4, 10).  The different dose of exercise 
used in the studies may be a factor contributing to the inconsistent findings.  
Additionally, obese individuals may have different responses to exercise 
intervention (11). Most previous exercise training studies, however, have 
examined ghrelin response in obese individuals.  To our knowledge, normal 
weight older women are a segment of the population that have yet to be studied 
in this capacity.  
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Purpose  
Therefore, the purpose of this study is to investigate the ghrelin response 
to two different doses of chronic exercise training in non-obese older women 
without a dietary intervention. Data are from the We Walk study (clinicaltrial.gov 
identifier: NCT01722136), in which older women participated in either a lower- or 
higher-dose of aerobic exercise training of 4 months; where the higher dose 
group will meet the current public health guidelines for adults regarding the 
amount of moderate intensity aerobic exercise per week, while the lower dose 
group will not. The specific aims of this thesis are outlined below. 
Specific Aim 1: To determine whether aerobic exercise training induced 
changes in ghrelin concentrations. 
Specific Aim 2: To determine whether the dose of aerobic exercise training 
influenced the changes in ghrelin concentrations. 
Specific Aim 3: To determine whether the changes in ghrelin 
concentrations were associated with changes in body weight and body 
composition.  
Hypothesis   
Existing literature in this field indicates that following aerobic exercise 
training programs, overweight to obese postmenopausal women see an increase 
in circulating ghrelin concentrations with weight loss.  Due to our study population 
consisting of non-obese postmenopausal women, we hypothesize there will be 
different changes in fasting ghrelin concentration in women participating in two 
different doses of exercise. 
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Methods 
The study for this thesis used data collected in the Women’s Energy 
Expenditure in Walking Programs (WeWalk) Study (ClinicalTrials.gov identifier: 
NCT01722136).  The WeWalk Study was a 4-month randomized control trial to 
investigate the effects of moderate intensity exercise of two different doses on 
energy expenditure in inactive older women.  Study procedures were reviewed 
and approved by the University of South Carolina Institutional Review Board in 
Columbia, South Carolina.  All participants were provided and signed a written 
informed consent.  
Participants and Enrollment Process 
The participants of the WeWalk study were non-obese (body mass index, 
BMI, 18 - 30 kg/m2) older women (60 – 75 years) from the Columbia 
metropolitan area.  They were recruited through advertisements in the local 
newspapers, email lists, and lunch n’ learn programs.  Exclusionary criteria 
included: taking beta blocker medication, metabolic disorders such as diabetes or 
thyroid disorders, presence of heart diseases, kidney disease, lung disease, 
cancer diagnoses within the last 5 years (except skin cancer), large weight 
fluctuations in the last 3 months (> 3%), currently smoking, current participation 
in another interventional study, or any contraindications to exercise.   
This thesis includes a subsample of participants from the WeWalk Study 
who had both baseline and post-intervention blood samples available for 
analysis.  The total sample size is 54, with 30 in the lower-dose group and 24 in 
the higher-dose group.  
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Graded exercise test 
Participants completed a maximal graded treadmill test at baseline and 
post-intervention.  The test was an incremental protocol, participants walked at a 
self-selected pace which remained constant throughout the duration of the test.  
Every 2 minutes, the incline of the treadmill was increased by 2%.  Volume of O2 
(VO2) and CO2 (VCO2) was measured via a metabolic cart (TrueOne 2400, 
ParvoMedics, Sandy, UT, USA).  Heart rate via a standard 12-lead ECG (Q-
Stress; Cardiac Science, Bothell, WA, USA) was monitored by a trained medical 
personnel. Blood pressure readings were taken approximately 30 seconds into 
each stage of the test.  For the test to be considered satisfactory, two of four 
criteria had to be met: a plateau in heart rate or VO2; respiratory exchange ratio 
greater than or equal to 1.10; a maximum heart rate greater than 90% of age-
predicted maximal heart rate (= 220-age); or a rating of perceived exertion 
greater than or equal to 17 on the Borg scale.  VO2peak was determined by the 
maximal 30-second averaged VO2 value sustained during the test. 
Exercise Intervention 
Participants were randomized into one of two moderate-intensity exercise 
groups.  The lower dose group had an energy expenditure goal of 8 kilocalories 
(kcal) per kilogram (kg) of body weight per week, and the higher dose group had 
an energy expenditure goal of 14 kcal/kg of body weight per week.  All training 
sessions were supervised and occurred at the Clinical Exercise Research Center 
at the University of South Carolina.  Both groups exercised for 16 weeks at an 
intensity of 50-55% of the participants heart rate reserve (HRR), which was 
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calculated using information obtained from each woman’s graded exercise test.  
Due to the participants being inactive prior to their participation in the study, 
training intensity started at 40% HRR and was increased by 5% every two weeks 
until the target level of 50-55% was achieved.  The exercise target was reached 
within 5 weeks for women in the low dose group and 8 weeks for those in the 
high dose group. Heart rate monitors (FT1; Polar; Lake Success, NY, USA) were 
worn during training sessions to ensure participants were exercising at the 
desired intensity throughout each exercise session.  Mid-way through the 16 
weeks of exercise training, participants completed a submaximal VO2 test to 
ensure they were exercising at the correct intensity given the exercise training 
group they were randomized into.  Heart rate was monitored and recorded every 
5 minutes throughout each training session, and blood pressure was measured 
before, at the midpoint of the exercise session, and after the exercise sessions.   
Body Composition 
 The dual-energy absorptiometry (enCORE, GE Healthcare model 8743, 
Waukesha, WI) full body scan was utilized to measure body fat percentage, lean 
mass (kg), fat mass (kg) and fat free mass (kg) at baseline and post-intervention.  
Height was measured to the nearest 0.1cm without shoes, and weight was 
measured to the nearest 0.1kg while the participant was wearing lightweight 
scrubs.  Two measurements for both height and weight were taken, and 
averages were used to calculate BMI (kg/m2).   
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Blood Sample Collection and Analysis 
Venous blood samples were collected at baseline and following the 
exercise intervention. Participants were instructed to fast (not including water) for 
at least 12 hours prior to blood draw visits.  Blood samples were drawn into 
EDTA tubes, centrifuged at 3,000 rpm for 20 minutes at 4 degrees Celsius.  
Plasma was then aliquoted into Eppendorf tubes and stored at -80 degrees 
Celsius until analysis.     
Plasma samples were thawed and re-centrifuged at 3,000 rpm at 4C° for 
20 minutes to remove any potential particulates before analysis of ghrelin 
concentration.  Plasma ghrelin was quantified by a multiplex immunoassay 
(Human Metabolic Hormone Magnetic Bead Panel, Millipore, Billerica, MA) per 
manufacturer instructions on a Magpix multiplexing system (Luminex, Austin, 
Texas, USA). The assay has a minimum detectable concentration of 13 pg/ml. 
The intra-assay coefficient of variance (CV) is < 10% and inter-assay CV is < 
15%. All samples were run in duplicates. 
Statistical Analysis 
Descriptive statistics will be first examined. Data will be reported as mean 
± SD for normally distributed variables and median (quartiles) for non-normally 
distributed variables, or frequencies in percentages. Change values in body 
weight, fat mass, fat-free mass, and ghrelin concentration will be calculated using 
values after intervention minus at baseline. Baseline values will be compared 
between the exercise groups using one-way analysis of variance (ANOVA) for 
normally distributed variables, Kruskal-Wallis test for non-normally distributed 
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continuous variables, and chi-square test for categorical variables. ANOVA with 
repeated measures including an interaction term (group by time) will be used to 
determine if the change after exercise training in body weight, fat mass, fat-free 
mass, and ghrelin concentration is different between the two exercise groups. If 
necessary, data will be transformed to achieve normal distribution prior to 
performing ANOVA. If the group by time interaction is significant, ANOVA with 
repeated measures will be performed in each group separately. Because of the 
reported association between body weight and body composition with ghrelin 
concentration in the literature, baseline and changes in body weight, fat mass, 
and fat-free mass will be adjusted for as covariates in the ANOVA. Pearson’s 
correlation between body weight and body composition and ghrelin concentration 
will be calculated for baseline values and change values from baseline to post-
intervention. A p value < 0.05 will be used to denote statistical significance. The 
SAS software (version 9.4, SAS Institute, Cary, NC) will be used to perform 
analyses.  Additionally, the power will be calculated with the achieved effect size, 
in order to inform future studies. 
Strengths and Limitations 
All exercise sessions being monitored by trained study staff is a strength 
of the study, as we can say with confidence that the participants were in fact 
exercising at the correct intensity as well as meeting the energy expenditure 
goals of the group they were assigned to.  No exercise sessions for any 
participant were done outside of the Clinical Exercise Research Center at USC. 
The inclusion of two doses will allow us to examine the effect of exercise dose.  
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The higher-dose exercise group exercised for an average of 160 minutes per 
week, which is just above the current public health recommendations for adults 
with respect to moderate intensity aerobic exercise.  This allows us to examine 
the ghrelin response in non-obese postmenopausal women meeting the 
guidelines.  The lower-dose exercise group exercised on average for 105 
minutes per week, which falls below the 150 minutes per week of moderate 
intensity aerobic exercise currently recommended for adults by the Centers for 
Disease Control. The inclusion of non-obese women will allow us to examine the 
response in individuals with relatively normal metabolism rather than obese 
individuals who may already present abnormal metabolic responses. On the 
other hand, the results only apply to older non-obese healthy women since 
ghrelin response to exercise training may be influenced by age, sex, and body 
weight status.  We have only collected fasting blood samples therefore we are 
not able to examine if there is any change in postprandial concentrations or the 
difference between high and low concentrations within a day.  Also, the duration 
between blood draw and the last exercise session varies from one to several 
days, and it is unknown how long any effects of acute or chronic exercise lasts. 
Therefore, we cannot differentiate whether any effect is due to the last exercise 
session or exercise training. Additionally, participants were not assessed for 
feelings of hunger or appetite at any point during the study; therefore, we cannot 
determine whether the ghrelin response to exercise training is associated with 
appetite change. 
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Literature Review 
 This section will review the physiology and function of ghrelin, how 
ghrelin relates to energy intake and body weight, the acute effects of exercise on 
ghrelin concentration, how chronic aerobic exercise training affects ghrelin, 
exercise training and body weight and body composition, as well as the relevant 
literature regarding ghrelin in animal models.  
Physiology and Function of Ghrelin 
Ghrelin is a 28 amino acid peptide secreted from the stomach and the only 
known circulating orexigenic hormone, discovered by Kojima et al in 1999 (21).  
Despite being a primarily peripherally secreted peptide, ghrelin exerts its major 
effects on the central nervous system, playing a role in the regulation of energy 
balance by increasing appetite and initiating food intake, as well as reducing fat 
utilization (3).  The first report of ghrelin’s involvement in appetite and the 
regulation of energy balance surfaced in a study focusing on growth hormone 
secretion, done by Arvat et al, where hunger was reported as a “collateral effect” 
of ghrelin administration (22). Though mostly produced by the P/D1 cells in the 
fundus of the stomach, there is also evidence that some ghrelin is produced in 
the ARC region of the hypothalamus, though its significance is still unknown (23). 
Ghrelin is acylated into its active form by ghrelin a-acyl-transferase, or 
GOAT (23). The acyated form of ghrelin has a half-life of approximately 10 
minutes, where the deacylated form has a half-life about threefold longer (24). 
The acylated form of ghrelin is the endogenous ligand for the growth hormone 
secretagogue receptor (GHSR), and is believed to be the form of ghrelin 
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responsible for controlling appetite and energy homeostasis (25). The GHSR is 
expressed throughout the hypothalamus, and the effects of ghrelin are mediated 
by the appetite stimulating neurons in the arcuate nucleus containing 
neuropeptide Y and agouti-regulated peptide (NPY/AgRP) (26). Though ghrelin 
circulates in two forms, acylated and desacylated, research has shown that the 
ratio of acylated ghrelin to total ghrelin remains consistent under most conditions 
(11).  
Many studies have investigated the effect of either an IV bolus or a 
continuous infusion of exogenous ghrelin. These studies, however, have utilized 
fairly high doses of ghrelin, therefore resulting in significantly supraphysiological 
concentrations.  Studies employing IV bolus application of ghrelin have used 
varying does between 40 micrograms (27) and 3 micrograms/kg body weight, 
resulting in plasma ghrelin concentrations of approximately 5,000 pg/ml (28-30).  
Continuous ghrelin infusion studies have used doses varying between 3.37 
nanograms/kg body weight/per minute to 50.7 nanograms/kg/min with infusion 
period lasting anywhere from 75 minutes to 360 minutes (31-35).  The total 
ghrelin levels witnessed at the lowest doses of continuous infusion protocols fell 
between a range of 2,500 and 5,000 picograms/ml.  More recent research of 
ghrelin infusion by Lippl et al utilized a low-dose ghrelin infusion method of 1 
ng/kg/min, mimicking a near-physiological dose of ghrelin, or a saline placebo. 
Participants were healthy, young males. In this study, the ghrelin infusion was 
started an inter-meal time period, which they argue is more appropriate 
physiological approach for examining ghrelin as the nadir of endogenous ghrelin 
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secretion occurs following a meal. The results from this study indicate an infusion 
of near-physiological levels of ghrelin did not have an effect on meal size, meal 
timing, or hunger stimulation (36). 
Although it appears supraphysiological doses of ghrelin administered via 
infusion are necessary to induce an appetite response, there may be other 
clinical applications of ghrelin, particularly in clinical diagnoses cachexia resulting 
from an array of pathologies such as chronic heart, renal, pulmonary, and other 
disease states, or those going through chemotherapy treatment.  Research by 
Akamizu et al sought to determine the clinical response to repeated 
administration of ghrelin to patients with functional dyspepsia, a chronic 
peristalsis disorder; and decreased food intake.  The participants in this study 
received an IV ghrelin infusion of 3 micrograms/kg for 30 minutes, twice daily, 
before breakfast and dinner meals, for two weeks.  The results found ghrelin 
administration in this cohort tended to increase food intake when compared to 
food intake level before and in the days following treatment (37).  Another study 
of ghrelin infusion in a clinical population investigated the effects of ghrelin 
administration in cancer patients with impaired appetite.  This study was an 
acute, randomized, placebo controlled cross-over trial where the participants 
received either a saline control infusion or an infusion of ghrelin at the rate of 5 
pmol/kg.  When compared to the saline control, there was a marked increase in 
energy intake during the ghrelin infusion trial of 31.7 ± 7%.  These results 
indicate ghrelin infusion could be an effective treatment for anorexia secondary to 
other clinical diagnoses (38). 
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Ghrelin, Energy Intake, & Body Weight 
Total plasma ghrelin concentrations increase pre-prandially and fall post-
prandially, indicating its role in the initiation of energy intake and short term 
energy homeostasis (4).  Ghrelin suppression following a meal tends to be 
greater after a larger, high calorie meal; but may also be influenced by the 
macronutrient breakdown of the meal - carbohydrates being more suppressive 
than proteins or fats (39).  The exact mechanisms of post-meal ghrelin 
suppression have yet to be fully discovered, but is likely related to the detection 
of nutrients in the stomach and possibly gastric emptying.  The post-prandial 
decrease in ghrelin concentration is seen in lean subjects, however in obese 
populations, this suppression is not witnessed, possibly leading to greater energy 
intake, further perpetuating the obesity issue (11).  As ghrelin has been 
associated with feelings of hunger and regulation of energy intake, its role in 
weight loss is of great interest. Ghrelin concentrations are found in circulation to 
be inversely proportional to body weight – higher circulating ghrelin 
concentrations are found in lower body weights, and lower circulating levels 
found in higher body weights (5, 7, 8).    
Following weight change, ghrelin typically responds in a compensatory 
fashion, with concentrations increasing with weight loss, and decreasing with 
weight gain (7).  Studies of long term caloric restriction ranging from three to six 
months resulting in significant weight loss have resulted in increased ghrelin 
concentrations (5, 9).  In addition to ghrelin, it has been shown that weight loss 
achieved through caloric restriction results in changes in appetite hormones such 
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as leptin, peptide tyrosine tyrosine (PYY) , and cholecystokinin (CCK); as well as 
changes in feelings of hunger that persist for 12 months following weight loss (1). 
These changes in appetite hormones may also improve the sensitivity of the 
appetite control system (40).   
Effects of single exercise bout on ghrelin 
The effect of acute bout of aerobic exercise on plasma ghrelin 
concentrations has been studied, but the findings are inconclusive.  Several 
studies have investigated the effect of a single session of exercise at various 
intensities and durations on ghrelin and found no changes in its concentration. 
These studies include a treadmill run for an hour at 73.5% of VO2max in young, 
healthy males and females (41), an intermittent treadmill running protocol (60% 
of VO2 max for 10 minutes, 75% VO2 max for 10 minutes, 90% VO2 max for 5 
minutes, and then 100% of VO2 max for 2 minutes) in young, well trained males 
(42), acute aerobic exercise at 50% or 70% of VO2 max for 20 minutes, or 90% 
VO2max intermittently for 10 minutes with 30 seconds followed by 30 seconds of 
rest in young, healthy males (43). All of the exercise bouts in these studies were 
of either high or moderate intensity, were of short duration, and the participants 
were young and lean.  The findings from these studies indicate a single session 
of exercise less than 20 minutes in duration have no effect on ghrelin 
concentrations upon the completion of exercise regardless of intensity in healthy, 
young populations. 
Erdmann et al. designed a study to investigate both the effect of exercise 
duration and the effect of exercise intensity on changes in plasma ghrelin 
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concentration (44). The intensity trial in this study varied slightly from the studies 
discussed above, as the exercise was 30 minutes in duration, and was done on a 
cycle ergometer as opposed to treadmill running.  Participants were young adults 
of normal weight.  The experimental trials for the intensity group had the 
participants cycle for 30 minutes at the low intensity of 50 W, and the high 
intensity trial was 100W.  In response to the 50W trial, ghrelin concentrations 
significantly rose from an average baseline value of 520.4 ± 82.7 pg/ml to 566.6 
± 86.2 pg/ml following the exercise compared to a resting control.  There were no 
significant changes in ghrelin concentration during the 100W trial.  The 
experimental trials for exercise duration had the participants cycle at 50W for 30, 
60, and 120 minutes. Ghrelin concentrations rose significantly 50-70 pg/ml during 
the respective period of exercise for the duration trial, but were not significantly 
different following any of the exercise trials.  These results indicate that low 
intensity exercise 30 minutes or longer may bring about changes in ghrelin 
concentration independent of duration.   
Additionally, other researchers have investigated the plasma ghrelin 
concentration response to an energy deficit either created by an acute exercise 
session, or achieved through a caloric deficit.  King et al compared a single 
exercise bout of a 90-minute run at 70% VO2max and an equal energy deficit 
created by calorie restriction from 2-4.75 hour (0 hour was defined as the time 
corresponding to immediately finishing exercise), and a control trial in healthy, 
lean, young adult males (4). Across trials, plasma acylated ghrelin was 
significantly higher in the caloric restriction trial when compared to the control 
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and exercise trials at time points 2, 3, 4.75, 6, 7, and 8 hours. There were no 
significant differences in ghrelin concentration at any of the time points between 
the control and exercise trials. Another study in normal weight males with a 
similar design showed different results. The exercise was 30 minutes of 
moderate-intensity (65% of VO2max) cycling (10). The caloric restriction was 
equivalent to the energy deficit in the exercise trial.  Their results found the area 
under the curve for acylated ghrelin concentration tended to be higher in the 
control trial than in the exercise deficit or calorie deficit trials from 0 to 1 hour, but 
did not differ between trials at any other time period. An increase in appetite, 
however, was found after caloric restriction, but not when the energy deficit was 
achieved via an acute bout of exercise. These changes in appetite were 
unrelated to changes in acylated ghrelin concentration. Although these two 
studies showed different results regarding ghrelin changes after caloric 
restriction, the collective results indicate effects of exercise on ghrelin may not be 
completely dependent on energy balance. 
Further, another study found treadmill walking at 55-60% of VO2 max for 
an hour in the evening induced an 18% lower acylated ghrelin concentration in 
the next morning compared to no-exercise control trial in normal weight 
individuals (11). Interestingly, in this study, obese participants did not show a 
change in ghrelin following the same exercise protocol, although lower levels of 
satiety following the exercise trial were reported when compared to the no-
exercise control trial. The authors concluded that exercise suppressed ghrelin 
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concentration in normal weight individuals, but this response in ghrelin to 
exercise was blunted in obese individuals.  
In summary, the intensity and duration of a single bout of exercise appear 
to influence the changes in ghrelin concentration. An exercise bout longer than 
30 minutes at low to moderate-intensities may induce changes in ghrelin; 
however, one study showed increases (44) while another one showed reductions 
(11).  Normal weight and obese individuals may have different responses to 
exercise. Also, exercise’s effects on ghrelin may not be completely dependent on 
the amount of energy deficit, since isocaloric deficits created by exercise or 
caloric restriction induces different changes in ghrelin and appetite sensation. 
Effects of chronic exercise training on ghrelin 
Fewer studies have investigated the effect of exercise training on ghrelin 
concentration. The inconsistent results are likely related to the various intensity 
and duration of the exercise sessions, length of training, and the characteristics 
of the participants.  
A 5-day exercise training of treadmill running in healthy, young males and 
females (45 minutes at 55% maximum heart rate reserve each day) did not result 
in significant changes in the concentration of acylated ghrelin compared to the 
no-exercise control (45). An exercise training of 12 weeks also found no change 
in ghrelin concentration. In this study, middle-aged overweight or obese men 
completing 60 minutes per session of aerobic training at 75-80% of their heart 
rate maximum for 3 sessions per week had a significant decline in body mass of 
2.0 kg, but had no change in fasting ghrelin concentration (46). 
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Similarly, another study of long duration (12 months) in overweight and 
obese postmenopausal women showed no change in fasting ghrelin 
concentration after exercise training (7). The exercise was 45 minutes of 
moderate to intense aerobic exercise five days per week; there was no significant 
change in ghrelin concentration, though the average weight loss was -2.4%.  
Among women who lost 5-10% of their starting body weight, the mean ghrelin 
concentration had a nonsignificant increase of 2.2%, and too few women lost 
more than 10% of their body weight in the exercise only group for a valid 
analysis. In the same study, a dietary restriction intervention resulted in women 
losing 5-10% of their starting body weight having an increase in ghrelin 
concentration of 4.2%, and those that lost more than 10% of their starting body 
weight had an increase in ghrelin concentration of 10.7%. They concluded that 
greater amounts of weight loss were associated with non-significantly greater 
increases in ghrelin concentrations. However, similar amounts of weight lost by 
diet compared to exercise alone seems to cause a greater increase in ghrelin 
concentration.  
In contrast, in another study, overweight, postmenopausal women 
experienced a significant increase of plasma ghrelin of +32 ± 16 pg/mL from a 
baseline of 599 ± 16 pg/mL after 12 months of aerobic exercise training (18).  
The aerobic exercise was 45 minutes and 5 days a week at 60-75% of their 
maximal heart rate.  There was a small but significant weight loss of 1.4kg (p < 
0.05).   
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The above studies in adults show that ghrelin either does not change or 
increases following aerobic exercise training. One study in obese adolescents 
found contradictory results (13).  In this study, adolescent participants were 
randomized into either high intensity or low intensity exercise training, and 
received the same nutritional, psychological and clinical counseling throughout 
12 weeks of the study.  The high intensity group exercised at an intensity that 
matched their ventilatory threshold, and the low intensity group exercised at an 
intensity approximately 20% lower than their respective ventilatory threshold.  
The exercise sessions were isoenergetic, where energy expenditure was set at 
350 kcal, and for three times a week.  Upon completion of the study, both 
exercise groups showed a reduction in ghrelin levels.  These results are 
intriguing as both groups saw a decrease in body weight; which corresponds to 
either an unchanged or an increased circulating ghrelin level in the studies 
performed in adults discussed above. Thus, age of participants may be a factor 
affecting the response of ghrelin to exercise training.  
Additionally, two other studies examined postprandial ghrelin response 
following exercise training. In one study, 12 non-obese, young sedentary women 
were randomized into non-exercising control group or a diet and exercise energy 
deficit group for three months. In the energy deficit group, exercise was done 5 
day a week at 70-80% of VO2max as determined by a maximal treadmill test; and 
there was an average weight loss of 2.5kg ± 0.9, as well as a significant increase 
in the 24 hour area under the curve of ghrelin. There were also significant 
changes in ghrelin including elevations in baseline from a pre-intervention 
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concentration of 1411 ± 107 pg/mL to a post-intervention concentration of 1764 ± 
113 pg/mL; lunch peak pre-intervention concentration of 1670 ± 121 pg/mL to 
post-intervention concentration of 2040 ± 105 pg/mL; dinner peak from pre-
concentration concentration of 1977 ±  123 pg/mL to post-intervention 
concentration of 2414 ± 134 pg/mL; and nocturnal peak pre-intervention 
concentration of 1862 ± 96 pg/mL to post-intervention concentration of 2372 ± 
148 pg/mL (17). In another study, sedentary, middle-aged, overweight or obese 
individuals (n=22) completed 12 weeks of moderate intensity exercise 5 times 
per week at 75% of their maximal heart rate (40).  The intervention resulted in a 
significant reduction in body weight (3.5 kg).  Their results yielded a significant 
increase in fasting acylated ghrelin following the exercise intervention from a 
baseline concentration of 37.3 ± 18.2 pmol/L to a post intervention concentration 
of 51.7 ± 26.0 pmol/L, as well as a significant increase in the suppression of 
acylated ghrelin postprandially.  These findings point to increased appetite 
sensations following exercise-induced weight loss; this change is also 
accompanied by a greater sensation of satiety to energy intake.   
In summary, previous studies of chronic exercise show inconsistent 
findings regarding fasting ghrelin concentration changes. One study showed that 
with similar weight loss, ghrelin responses to exercise and caloric restriction were 
different (21), suggesting the exercise effect on ghrelin is not completely 
dependent on weight change. This is also supported by other studies that a small 
weight loss resulted in increased fasting ghrelin (43), but greater weight loss did 
not result in weight loss in another study (21).  Additionally, age of participants or 
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the length of being obese may affect ghrelin response (11),(47).  Further, the 
ghrelin changes in response to exercise training is also shown in the amplitude of 
change during a day. 
Exercise Effects on Body Weight and Composition 
Previous studies have examined the effects of aerobic exercise training 
alone on body weight and body composition. In this section, several large scale 
exercise trials are reviewed.  
One study of 400 inactive older women with a BMI between 22–40 kg/m2 
compared the effects of 300 minutes per week of moderate to vigorous intensity 
exercise to 150 minutes per week (48). The results found high volume (300 
minutes per week) was better than moderate volume (150 minutes per week) in 
regards to reducing total body fat. The high volume exercise group experienced 
an average body fat loss of -2.2%, while the moderate volume group experienced 
an average body fat loss of -1.2%.  There was also a dose-response relationship 
for decreases in BMI, waist circumference measurements, and waist to hip ratio.  
The Studies of Targeted Risk Reduction Intervention through Defines 
Exercise (STRRIDE) study consisted of an eight month exercise program with 
participants randomized into one of three groups: high amount with vigorous 
intensity, equivalent of 20 miles per week at 65-80% VO2max, low amount with 
vigorous intensity, equivalent of 12 miles per week at 65-80% VO2max, and low 
amount of moderate intensity, equivalent of 12 miles per week at 40-55% 
VO2max  (49).  The results indicate that in overweight participants, both of the 
low amount groups lost body weight and fat, and the high amount group lost 
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more body weight and body fat compared to the low amount groups; all in the 
absence of caloric restriction. There was a clear dose response relationship 
between the amount of exercise done per week and weight loss: the low amount 
moderate intensity group lost an average of approximately 2kg, the low amount 
vigorous intensity group lost approximately 2.5kg, and the high amount vigorous 
intensity group lost the most weight at approximately 5kg.  These findings further 
solidify exercise can be an effective approach to losing both body weight and fat 
in overweight adults.  
The Midwest Exercise Trial set out to investigate the efficacy of a known 
amount of exercise to prevent weight gain or to produce weight loss in 
overweight and moderately obese adults (50).  Participants randomized to the 
exercise group exercised at 75% heart rate reserve (HRR) for 45 minutes, five 
days per week.  The targeted energy expenditure of each exercise session was 
approximately 400 kilocalories.  The control group was instructed to maintain 
their usual physical activity and dietary habits.  The results found that exercise 
had a significant effect on body weight and composition; however the effects 
were different between men and women.  Men in the exercise group lost an 
average of 5.2 kilograms of body weight, which was approximately -6% of 
baseline weight.  Almost all (96%) of the weight loss came from body fat, and 
visceral fat decreased by 23%.  Women assigned to the exercise group did not 
experience weight loss; however they did avoid the 3 kg weight gain that was 
seen in the women in the control group.   
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The Dose Response in Exercise in Women (DREW) study was a 
randomized dose-response exercise trial in pre-hypertensive obese 
postmenopausal women.  There were 3 exercise groups with incrementally 
higher doses of energy expenditure and a non-exercise control group (51).  The 
three exercise groups were classified by energy expenditure as follows: 4 
kcal/kg/week, 8 kcal/kg/week, and 12 kcal/kg/week.  The women in the exercise 
groups participated in 3 or 4 training sessions each week, at approximately 50% 
of their respective VO2max, for six months. Upon completion of the study, all 
exercising groups had lost a significant amount of weight: the 4 kcal/kg/week 
group had lost an average of -1.4 kg, the 8 kcal/kg/week group an average of -
2.1 kg, and the 12 kcal/kg/week group an average of -1.5 kg.    
The Sex Hormones and Physical Exercise study (SHAPE-2) study was a 
randomized control trial done in postmenopausal women.  The overall design of 
the study was intended to have participants in the experimental groups lose body 
weight.  One arm was “mainly exercise induced weight loss”, where the 
participants were assigned to follow an intensive 4 hour per week exercise 
program consisting of mainly endurance exercise with some added strength 
training; and a small caloric deficit of approximately 250 kcal/day.  The other 
experimental arm was calorie restriction only.  The experimental period lasted for 
14 weeks.  After the 14 weeks, the “mainly exercise” group accomplished an 
average weight loss of -5.5kg (6.6%). The results from the SHAPE-2 study 
indicate losing weight through exercise as opposed to dietary restriction alone 
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resulted in a larger loss of fat mass and preservation of lean mass, which is an 
important consideration especially in older populations  (52).  
In summary, weight loss can be achieved by aerobic exercise training 
alone, which appears to be up to approximately 7%. There is also an 
accompanying overall loss of adiposity.  The amount and intensity of exercise 
play a role in the amount of weight and fat loss. 
Animal Research on Ghrelin 
Numerous studies have utilized animal models to confirm the physiological 
function of ghrelin and its receptor.  Work by Zigman and colleagues confirmed 
the GHSR as the only receptor responsible for ghrelin’s acute orexigenic 
properties (53).  To investigate the physiological significance of GHSR 
transcriptional blockage on long term body weight maintenance, researchers fed 
the GHSR-null mice and their wild-type (WT) littermates a Western-type high fat 
diet (HFD) for 19 weeks. Body composition was determined by multiple methods, 
including DXA, nuclear magnetic resonance (NMR) and carcass analysis via 
lyophilization and standard ether extraction.  In female mice, after 8 weeks of 
HFD feeding, the GHSR-null mice weighed significantly less than the WT mice 
and thereafter continued to increasingly diverge in body weight.  After 19 weeks, 
the GHSR-null mice weighed 12.7% less than their WT counterparts; and had 
46.5% less fat mass than the WT mice.  In male mice, the GHSR-null mice 
weighed 10.9% less than their WT counterparts after 6 weeks on HFD, and at 
completion of the study had 16.5% less fat mass when compared to the WT male 
mice.  The results also indicate GHSR-null mice on HFD are hypophagic.  The 
 45   
GHSR-null mice manifested statistically significantly lower average weekly food 
intake compared to WT mice.  Researchers concluded that ghrelin signaling via 
GHSR is necessary for the full development of diet induced obesity. The results 
also suggest a sex difference on fat mass. 
Other research with animals has examined the effects of acute and 
chronic exercise on ghrelin.  One study compared acute aerobic exercise to 
chronic aerobic exercise in rats.  In the acute arm, Sprague-Dawley rats were 
forced to run on a treadmill for 40 minutes; and following the exercise, the rats 
consumed smaller meals and had decreased hypothalamic ghrelin for the next 
three hours (14).  The arm investigating chronic aerobic exercise had obese rats 
run on a treadmill 5 days per week for 8 weeks.  Compared to the controls, the 
exercising group lost body weight, consumed smaller meals, and had lower 
fasting hypothalamic ghrelin concentrations (14).  Therefore, both the acute and 
chronic exercise showed suppressive effects on ghrelin concentrations.   
Another study in rats examined the relationship between chronic 
resistance exercise and ghrelin concentration (54).  The rats performed 
resistance exercise five times per week for five weeks.  The results found after 
the five weeks of training, the rats body mass decreased, and total fasting ghrelin 
concentration decreased by 20%. This study also supports a suppressive effect 
of exercise on ghrelin. 
Summary 
Ghrelin is the only known circulating orexigenic hormone, and given 
today’s obesity epidemic, understanding its response to exercise as a means to 
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control body weight is critical.  It circulates in inverse proportion to body weight, 
and this relationship is maintained following weight loss.  The effect of acute 
exercise on ghrelin concentration has been studied, and most of those studies 
included a relatively short exercise bout of 20 minutes or less resulted in no 
change in ghrelin concentration, regardless of the intensity that the exercise was 
performed. It should also be noted that these studies were conducted in young, 
healthy participants.  A single exercise bout greater than 30 minutes may induce 
change in ghrelin concentrations, however one study showed an increase (44) 
while another showed a decrease (5). Another study has also produced results 
that may lead us to believe it is possible that normal weight and obese individuals 
do not have the same ghrelin response to exercise (11).  Studies of ghrelin 
concentration changes following long term exercise training studies in adults 
have shown that ghrelin concentration either does not change, or increases.  In 
many of these studies, participants were overweight and over the course of 
exercise training lost weight, though it may not have been a significant amount; 
and an increase in ghrelin concentration following weight loss is expected.  
However, a study in adolescents where significant weight loss occurred resulted 
in a decrease in plasma ghrelin levels, contradicting the response shown in 
adults (48).   
Normal weight older women appear to be one segment of the population 
that has not been studied previously regarding the ghrelin response to chronic 
exercise training. As indicated by a study of acute exercise (11), normal weight 
and obese individuals may have differing responses. Many studies have 
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investigated the effect of intensity of exercise on changes in ghrelin 
concentration, however for this study we plan to examine the role that exercise 
dose potentially plays in changes in ghrelin concentration. This study will be the 
first, to our knowledge, to investigate changes in ghrelin concentration in older 
normal weight women without intentional weight loss. In this thesis, ghrelin 
concentrations before and after aerobic exercise at two different doses will be 
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